Myeloid Neoplasm: Clinical Trials

3 trials for Myeloid Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 3
Phase 11Active not recruiting 1

Follow Myeloid Neoplasm: new trials by email Literature Review of Myeloid Neoplasm trials Research Report on Myeloid Neoplasm

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
Decitabine, Filgrastim - Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 2Active not recruitingFranziska Wachter292023-04-192026-08-20
Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms
CPX-351, MHA, Allogeneic Hematopoietic Stem Cell Transplantation - Myeloid Neoplasm
Phase 2Active not recruitingSt. Jude Children's Research Hospital252023-01-172026-10-15
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Azacitidine, Pevonedistat, Venetoclax - Acute Myeloid Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
Phase 1 / Phase 2Active not recruitingM.D. Anderson Cancer Center402019-02-272026-07-16

Narrower conditions

Leukemia, Myeloid, Acute (3)  ·  Myelodysplastic Syndromes (3)  ·  Congenital Bone Marrow Failure Syndromes (1)  ·  Hypereosinophilic Syndrome (1)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Leukemia, Myelomonocytic, Juvenile (1)  ·  Leukemia, Neutrophilic, Chronic (1)  ·  Myeloproliferative Disorders (1)  ·  Polycythemia Vera (1)  ·  Primary Myelofibrosis (1)  ·  Thrombocythemia, Essential (1)  ·  Thrombocytosis (1)

Broader conditions

Bone Marrow Diseases (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Leukemia (3)  ·  Leukemia, Myeloid (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Myelodysplastic-Myeloproliferative Diseases (2)  ·  Blood Coagulation Disorders (1)  ·  Blood Platelet Disorders (1)  ·  Bone Marrow Failure Disorders (1)  ·  Bone Marrow Neoplasms (1)  ·  Chronic Disease (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disease Attributes (1)

Interventions

Azacitidine (1)  ·  CPX-351 (1)  ·  Cytarabine (1)  ·  Daunorubicin (1)  ·  Decitabine (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Methotrexate (1)  ·  Stem Cell Transplantation (1)  ·  pevonedistat (1)  ·  venetoclax (1)

Sponsors

Franziska Wachter (1)  ·  M.D. Anderson Cancer Center (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (3)

Top investigators

Franziska Wachter, MD (1)  ·  Marcin Wlodarski, MD, PhD (1)  ·  Nicholas Short (1)  ·  Raul C. Ribeiro, MD (1)

Results publications

PMID 37422688